Amdocs (DOX) Projected to Post Earnings on Wednesday

Key Points

• Amdocs is set to report Q2 2026 results after the market close on Wednesday, May 13, 2026; analysts expect $1.77 EPS and $1.1661 billion in revenue, with a conference call at 5:00 PM ET.
• In the prior quarter Amdocs beat estimates with $1.81 EPS and roughly $1.16 billion in revenue, and analysts forecast about $7 EPS for the current and next fiscal years.
• The stock trades around $65.44 (52‑week range $62.75–$95.41) with a P/E of 12.66 and a MarketBeat consensus target of $92.33, reflecting analyst upside despite recent weakness.

Amdocs (NASDAQ:DOX - Get Free Report) is expected to be posting its Q2 2026 results after the market closes on Wednesday, May 13th. Analysts expect the company to announce earnings of $1.77 per share and revenue of $1.1661 billion for the quarter. Investors are encouraged to explore the company's upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, May 13, 2026 at 5:00 PM ET.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The firm had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.15 billion. During the same quarter in the prior year, the firm earned $1.66 EPS. The business's revenue for the quarter was up 4.1% compared to the same quarter last year. On average, analysts expect Amdocs to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Amdocs Stock Performance

NASDAQ DOX opened at $65.44 on Wednesday. Amdocs has a 52-week low of $62.75 and a 52-week high of $95.41. The company has a fifty day moving average of $66.17 and a 200-day moving average of $74.65. The company has a market capitalization of $7.06 billion, a P/E ratio of 12.66, a P/E/G ratio of 1.15 and a beta of 0.40. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06.

Institutional Trading of Amdocs

Institutional investors have recently made changes to their positions in the stock. Amundi raised its holdings in Amdocs by 73.0% during the 1st quarter. Amundi now owns 13,778 shares of the technology company's stock valued at $1,217,000 after buying an additional 5,816 shares during the last quarter. Millennium Management LLC lifted its position in shares of Amdocs by 458.3% in the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company's stock worth $6,135,000 after purchasing an additional 55,038 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Amdocs by 12.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company's stock valued at $30,300,000 after purchasing an additional 37,087 shares in the last quarter. Empowered Funds LLC boosted its stake in shares of Amdocs by 12.0% during the 1st quarter. Empowered Funds LLC now owns 15,979 shares of the technology company's stock valued at $1,462,000 after purchasing an additional 1,709 shares in the last quarter. Finally, Jane Street Group LLC increased its position in shares of Amdocs by 195.4% during the first quarter. Jane Street Group LLC now owns 115,929 shares of the technology company's stock valued at $10,608,000 after buying an additional 76,683 shares during the period. Hedge funds and other institutional investors own 92.02% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on DOX. Weiss Ratings reiterated a "hold (c)" rating on shares of Amdocs in a report on Tuesday, January 27th. Wall Street Zen upgraded Amdocs from a "hold" rating to a "buy" rating in a research report on Saturday, April 18th. Stifel Nicolaus reduced their price target on shares of Amdocs from $97.00 to $88.00 and set a "buy" rating on the stock in a research report on Wednesday, February 4th. Finally, Barclays lowered their price objective on shares of Amdocs from $111.00 to $92.00 and set an "overweight" rating for the company in a report on Wednesday, February 4th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, Amdocs currently has a consensus rating of "Moderate Buy" and an average target price of $92.33.

About Amdocs

Amdocs NASDAQ: DOX is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs' product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra'anana, Israel.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.